Steven W. Andrews
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Synthetic Organic Chemistry Methods, Pain Mechanisms and Treatments, Inflammatory mediators and NSAID effects, Neuropeptides and Animal Physiology
Most-Cited Works
- → Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer(2013)601 cited
- → The Pharmacology of Bimatoprost (Lumigan™)(2001)213 cited
- → Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)(2008)173 cited
- → Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024)(2003)146 cited
- → Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease(2013)140 cited
- → Colonization of the Human Oral Cavity by a Streptococcus mutans Mutant Producing Increased Bacteriocin(1987)103 cited
- → Characterization of degenerative human facet joints and facet joint capsular tissues(2015)71 cited
- → Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers(2010)67 cited
- → Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis(2016)63 cited
- → LOXO-305, A Next Generation Reversible BTK Inhibitor, for Overcoming Acquired Resistance to Irreversible BTK Inhibitors(2018)62 cited